| - GRCh37:
- Chr2:144657717-159178136
- GRCh38:
- Chr2:143900149-158321624
| ACVR1, ACVR1C, ACVR2A, ARL5A, ARL6IP6, CACNB4, CCDC148, CCDC148-AS1, CYTIP, EPC2, ERMN, FLJ46875, FMNL2, GALNT13, GALNT13-AS1, GALNT5, GPD2, GTDC1, KCNJ3, KIF5C, LINC01412, LINC01817, LINC01818, LINC01876, LINC01911, LINC01920, LINC01931, LINC01966, LINC02612, LINC02993, LOC101928386, LOC101929319, LOC107228318, LOC108348024, LOC110120671, LOC110120673, LOC110120674, LOC110120675, LOC110120706, LOC110120708, LOC110120710, LOC110120715, LOC110120731, LOC110120736, LOC110121086, LOC110121209, LOC111556122, LOC111721705, LOC112806051, LOC112806054, LOC112806055, LOC115945200, LOC120961787, LOC120977009, LOC121725105, LOC122819163, LOC122819164, LOC122819165, LOC122819166, LOC122819167, LOC122847293, LOC122847294, LOC122847295, LOC122847296, LOC122847297, LOC122847298, LOC126806362, LOC126806363, LOC126806364, LOC126806365, LOC126806366, LOC126806367, LOC126806368, LOC126806369, LOC126806370, LOC126806371, LOC126806372, LOC126806373, LOC126806374, LOC126806375, LOC126806376, LOC126806377, LOC126806378, LOC126806379, LOC126806380, LOC126806381, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LYPD6, LYPD6B, MBD5, MIR4773-1, MIR4773-2, MIR9899, MMADHC, MMADHC-DT, NEB, NMI, NR4A2, ORC4, PRPF40A, RBM43, RIF1, RND3, RPRM, STAM2, TEX41, TNFAIP6, TRA-CGC3-1, TRG-GCC2-2, UPP2, ZEB2, ZEB2-AS1 | | See cases | Pathogenic (Jul 30, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr2:148009516-158712890
- GRCh38:
- Chr2:147251948-157856378
| ACVR1, ACVR1C, ACVR2A, ARL5A, ARL6IP6, CACNB4, CYTIP, EPC2, ERMN, FLJ46875, FMNL2, GALNT13, GALNT13-AS1, GALNT5, GPD2, KCNJ3, KIF5C, LINC01817, LINC01818, LINC01876, LINC01920, LINC01931, LINC02612, LOC101929319, LOC108348024, LOC110120673, LOC110120674, LOC110120675, LOC110120708, LOC110120710, LOC110120736, LOC110121086, LOC111556122, LOC112806054, LOC112806055, LOC115945200, LOC120961787, LOC120977009, LOC122819165, LOC122819166, LOC122819167, LOC122847293, LOC122847294, LOC122847295, LOC122847296, LOC122847297, LOC122847298, LOC126806365, LOC126806366, LOC126806367, LOC126806368, LOC126806369, LOC126806370, LOC126806371, LOC126806372, LOC126806373, LOC126806374, LOC126806375, LOC126806376, LOC126806377, LOC126806378, LOC126806379, LOC126806380, LOC126806381, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LYPD6, LYPD6B, MBD5, MIR4773-1, MIR4773-2, MIR9899, MMADHC, MMADHC-DT, NEB, NMI, NR4A2, ORC4, PRPF40A, RBM43, RIF1, RND3, RPRM, STAM2, TNFAIP6, TRA-CGC3-1, TRG-GCC2-2 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr2:149674855-164061133
- GRCh38:
- Chr2:148917286-163204623
| ACVR1, ACVR1C, ARL5A, ARL6IP6, BAZ2B, BAZ2B-AS1, CACNB4, CCDC148, CCDC148-AS1, CD302, CYTIP, DAPL1, DPP4, DPP4-DT, ERMN, FAP, FLJ46875, FMNL2, GALNT13, GALNT13-AS1, GALNT5, GCA, GCG, GPD2, IFIH1, ITGB6, KCNH7, KCNH7-AS1, KCNJ3, KIF5C, LINC01806, LINC01817, LINC01818, LINC01876, LINC01920, LINC01931, LINC02478, LINC02612, LOC101929319, LOC101929532, LOC108175345, LOC108281133, LOC108348024, LOC110120673, LOC110120674, LOC110120675, LOC110120676, LOC110120708, LOC110120710, LOC110120736, LOC110121086, LOC110121120, LOC110121242, LOC111556122, LOC112806054, LOC112806055, LOC112806056, LOC114827830, LOC115945200, LOC117152610, LOC117152611, LOC120961787, LOC120977009, LOC120977010, LOC120977011, LOC120977012, LOC121725105, LOC122819166, LOC122819167, LOC122847293, LOC122847294, LOC122847295, LOC122847296, LOC122847297, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC122847302, LOC122847303, LOC122847304, LOC122847305, LOC122847306, LOC122847307, LOC126806368, LOC126806369, LOC126806370, LOC126806371, LOC126806372, LOC126806373, LOC126806374, LOC126806375, LOC126806376, LOC126806377, LOC126806378, LOC126806379, LOC126806380, LOC126806381, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, LOC126806391, LOC126806392, LOC126806393, LY75, LY75-CD302, LYPD6, LYPD6B, MARCHF7, MIR4773-1, MIR4773-2, MIR4785, MIR6888, MIR9899, MMADHC, MMADHC-DT, NEB, NMI, NR4A2, PKP4, PKP4-AS1, PLA2R1, PRPF40A, PSMD14, PSMD14-DT, RBM43, RBMS1, RIF1, RND3, RPRM, SLC4A10, STAM2, TANC1, TANK, TANK-AS1, TBR1, TNFAIP6, TRA-CGC3-1, TRG-GCC2-2, UPP2, WDSUB1 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152788858-160276245
- GRCh38:
- Chr2:151932344-159419734
| ACVR1, ACVR1C, ARL6IP6, BAZ2B, CACNB4, CCDC148, CCDC148-AS1, CYTIP, DAPL1, ERMN, FLJ46875, FMNL2, GALNT13, GALNT13-AS1, GALNT5, GPD2, KCNJ3, LINC01876, LOC110120673, LOC110120674, LOC110120675, LOC110120708, LOC110120710, LOC110120736, LOC110121120, LOC110121242, LOC111556122, LOC112806055, LOC120977010, LOC120977011, LOC121725105, LOC122847296, LOC122847297, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC126806374, LOC126806375, LOC126806376, LOC126806377, LOC126806378, LOC126806379, LOC126806380, LOC126806381, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, MIR6888, NR4A2, PKP4, PKP4-AS1, PRPF40A, RPRM, STAM2, TANC1, TRA-CGC3-1, TRG-GCC2-2, UPP2, WDSUB1 | | See cases | Pathogenic (Dec 22, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr2:154466227-159041637
- GRCh38:
- Chr2:153609714-158185125
| ACVR1, ACVR1C, CCDC148, CCDC148-AS1, CYTIP, ERMN, FLJ46875, GALNT13, GALNT13-AS1, GALNT5, GPD2, KCNJ3, LINC01876, LOC110120673, LOC110120674, LOC110120675, LOC110120708, LOC110120710, LOC110120736, LOC111556122, LOC121725105, LOC122847298, LOC126806381, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, NR4A2, TRA-CGC3-1, TRG-GCC2-2, UPP2 | | See cases | Pathogenic (Sep 21, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr2:155150555-176854100
- GRCh38:
- Chr2:154294042-175989372
| SLC25A12, SLC38A11, SPC25, SLC4A10, SNORA70F, SNORD3K, SP3, SP5, SP9, SSB, STK39, TANC1, TANK, TANK-AS1, TBR1, TLK1, TRA-CGC3-1, TRG-GCC2-2, TTC21B, TTC21B-AS1, UBR3, UPP2, WDSUB1, WIPF1, XIRP2, XIRP2-AS1, ABCB11, ACVR1, ACVR1C, ATF2, ATP5MC3, B3GALT1, B3GALT1-AS1, BAZ2B, BAZ2B-AS1, BBS5, CCDC148, CCDC148-AS1, CD302, CDCA7, CERS6, CERS6-AS1, CFAP210, CHN1, CHRNA1, CIR1, COBLL1, CSRNP3, CYBRD1, CYTIP, DAPL1, DCAF17, DHRS9, DLX1, DLX2, DLX2-DT, DPP4, DPP4-DT, DYNC1I2, ERICH2, ERICH2-DT, ERMN, FAP, FASTKD1, FIGN, FLJ46875, G6PC2, GAD1, GALNT13, GALNT13-AS1, GALNT3, GALNT5, GCA, GCG, GORASP2, GPD2, GPR155, GPR155-DT, GRB14, HAT1, IFIH1, ITGA6, ITGA6-AS1, ITGB6, KCNH7, KCNH7-AS1, KCNJ3, KLHL23, KLHL41, LINC01124, LINC01305, LINC01806, LINC01876, LINC01960, LINC02478, LNPK, LOC100506124, LOC101929532, LOC101929633, LOC102724058, LOC108175345, LOC108281133, LOC110120601, LOC110120624, LOC110120625, LOC110120626, LOC110120673, LOC110120674, LOC110120675, LOC110120676, LOC110120677, LOC110120678, LOC110120701, LOC110120708, LOC110120710, LOC110120725, LOC110120730, LOC110120736, LOC110120790, LOC110120809, LOC110121120, LOC110121216, LOC110121242, LOC111413009, LOC111556122, LOC112806056, LOC112806057, LOC112806058, LOC112806059, LOC112806060, LOC114827830, LOC115945201, LOC117152610, LOC117152611, LOC120977010, LOC120977011, LOC120977012, LOC120977013, LOC120977014, LOC120977015, LOC121725105, LOC121725106, LOC121725107, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC122847302, LOC122847303, LOC122847304, LOC122847305, LOC122847306, LOC122847307, LOC122847308, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC122847317, LOC122847318, LOC122847319, LOC122847320, LOC122861240, LOC122861241, LOC122861242, LOC122861243, LOC122861244, LOC122861245, LOC122861246, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, LOC126806391, LOC126806392, LOC126806393, LOC126806394, LOC126806395, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LOC126806404, LOC126806405, LOC126806406, LOC126806407, LOC126806408, LOC126806409, LOC126806410, LOC126806411, LOC126806412, LRP2, LY75, LY75-CD302, MAP3K20, MAP3K20-AS1, MARCHF7, METAP1D, METTL5, METTL8, MIR4774, MIR4785, MIR6888, MIR933, MYO3B, MYO3B-AS1, NOSTRIN, NR4A2, OLA1, PDK1, PHOSPHO2, PHOSPHO2-KLHL23, PKP4, PKP4-AS1, PLA2R1, PPIG, PSMD14, PSMD14-DT, RAPGEF4, RAPGEF4-AS1, RBMS1, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SCRN3 | | See cases | Pathogenic (Mar 10, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr2:155223300-167905412
- GRCh38:
- Chr2:154366788-167048902
| ACVR1, ACVR1C, BAZ2B, BAZ2B-AS1, CCDC148, CCDC148-AS1, CD302, COBLL1, CSRNP3, CYTIP, DAPL1, DPP4, DPP4-DT, ERMN, FAP, FIGN, FLJ46875, GALNT13, GALNT13-AS1, GALNT3, GALNT5, GCA, GCG, GPD2, GRB14, IFIH1, ITGB6, KCNH7, KCNH7-AS1, KCNJ3, LINC01806, LINC01876, LINC02478, LOC100506124, LOC101929532, LOC101929633, LOC102724058, LOC108175345, LOC108281133, LOC110120601, LOC110120673, LOC110120674, LOC110120675, LOC110120676, LOC110120677, LOC110120708, LOC110120710, LOC110120725, LOC110120736, LOC110121120, LOC110121242, LOC111413009, LOC111556122, LOC112806056, LOC112806057, LOC114827830, LOC117152610, LOC117152611, LOC120977010, LOC120977011, LOC120977012, LOC120977013, LOC121725105, LOC121725106, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC122847302, LOC122847303, LOC122847304, LOC122847305, LOC122847306, LOC122847307, LOC122847308, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, LOC126806391, LOC126806392, LOC126806393, LOC126806394, LOC126806395, LOC126806396, LY75, LY75-CD302, MARCHF7, MIR4785, MIR6888, NR4A2, PKP4, PKP4-AS1, PLA2R1, PSMD14, PSMD14-DT, RBMS1, SCN1A, SCN1A-AS1, WDSUB1, SCN2A, SCN3A, SCN7A, SCN9A, SLC38A11, SLC4A10, SNORA70F, TANC1, TANK, TANK-AS1, XIRP2, TBR1, TRA-CGC3-1, TRG-GCC2-2, TTC21B, TTC21B-AS1, UPP2 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr2:155363751-158667217
- GRCh38:
- Chr2:154507239-157810705
| ACVR1, ACVR1C, CYTIP, ERMN, FLJ46875, GALNT5, GPD2, KCNJ3, LINC01876, LOC110120673, LOC110120674, LOC110120675, LOC110120708, LOC110120710, LOC110120736, LOC122847298, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, NR4A2, TRA-CGC3-1, TRG-GCC2-2 | | Autism spectrum disorder | Likely pathogenic (Oct 12, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158274685-159134033
- GRCh38:
- Chr2:157418173-158277521
| ACVR1, ACVR1C, CCDC148, CCDC148-AS1, CYTIP, LOC121725105, LOC126806386, LOC126806387, LOC126806388, LOC126806389, UPP2 | | See cases | Uncertain significance (Mar 10, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr2:158593007
- GRCh38:
- Chr2:157736495
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593252
- GRCh38:
- Chr2:157736740
| ACVR1 | | Progressive myositis ossificans | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593281
- GRCh38:
- Chr2:157736769
| ACVR1 | | Progressive myositis ossificans | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593291
- GRCh38:
- Chr2:157736779
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593292
- GRCh38:
- Chr2:157736780
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593332
- GRCh38:
- Chr2:157736820
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593357
- GRCh38:
- Chr2:157736845
| ACVR1 | | Progressive myositis ossificans | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593543
- GRCh38:
- Chr2:157737031
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593622
- GRCh38:
- Chr2:157737110
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593685
- GRCh38:
- Chr2:157737173
| ACVR1 | | Progressive myositis ossificans | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593729
- GRCh38:
- Chr2:157737217
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593793
- GRCh38:
- Chr2:157737281
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593833
- GRCh38:
- Chr2:157737321
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593839-158594128
- GRCh38:
- Chr2:157737327-157737616
| ACVR1 | P482fs | not provided | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593860
- GRCh38:
- Chr2:157737348
| ACVR1 | | Progressive myositis ossificans | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593861
- GRCh38:
- Chr2:157737349
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593891
- GRCh38:
- Chr2:157737379
| ACVR1 | | Progressive myositis ossificans | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593905
- GRCh38:
- Chr2:157737393
| ACVR1 | | not provided, Progressive myositis ossificans | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158593906
- GRCh38:
- Chr2:157737394
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593996
- GRCh38:
- Chr2:157737484
| ACVR1 | | Progressive myositis ossificans | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158593998
- GRCh38:
- Chr2:157737486
| ACVR1 | | not provided, Progressive myositis ossificans | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158594051-158594052
- GRCh38:
- Chr2:157737539-157737540
| ACVR1 | D508* | not provided | Uncertain significance (Oct 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594060
- GRCh38:
- Chr2:157737548
| ACVR1 | | not provided, Progressive myositis ossificans | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158594064
- GRCh38:
- Chr2:157737552
| ACVR1 | | not provided | Likely benign (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594067
- GRCh38:
- Chr2:157737555
| ACVR1 | | not provided, Progressive myositis ossificans | Benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158594100
- GRCh38:
- Chr2:157737588
| ACVR1 | | not provided | Likely benign (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594124
- GRCh38:
- Chr2:157737612
| ACVR1 | | not provided | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594154
- GRCh38:
- Chr2:157737642
| ACVR1 | | not provided | Likely benign (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594167
- GRCh38:
- Chr2:157737655
| ACVR1 | S469C | not provided | Uncertain significance (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594169
- GRCh38:
- Chr2:157737657
| ACVR1 | | not provided | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594175
- GRCh38:
- Chr2:157737663
| ACVR1 | | not provided | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594178-158594179
- GRCh38:
- Chr2:157737666-157737667
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Jan 26, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594197
- GRCh38:
- Chr2:157737685
| ACVR1 | | not provided | Likely benign (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594315
- GRCh38:
- Chr2:157737803
| ACVR1 | | not provided | Benign (May 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594408
- GRCh38:
- Chr2:157737896
| ACVR1 | | not provided | Benign (May 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594932
- GRCh38:
- Chr2:157738420
| ACVR1 | | not provided | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594937
- GRCh38:
- Chr2:157738425
| ACVR1 | | not provided | Likely benign (Oct 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594945
- GRCh38:
- Chr2:157738433
| ACVR1 | | not provided | Benign (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594947
- GRCh38:
- Chr2:157738435
| ACVR1 | | Progressive myositis ossificans, not provided | Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158594953
- GRCh38:
- Chr2:157738441
| ACVR1 | P465L | not provided, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Aug 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:158594955
- GRCh38:
- Chr2:157738443
| ACVR1 | D464E | not provided | Uncertain significance (Nov 24, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594973
- GRCh38:
- Chr2:157738461
| ACVR1 | | not provided | Likely benign (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594997
- GRCh38:
- Chr2:157738485
| ACVR1 | | not provided | Likely benign (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158594999
- GRCh38:
- Chr2:157738487
| ACVR1 | V450M | not provided | Uncertain significance (Sep 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595009
- GRCh38:
- Chr2:157738497
| ACVR1 | K446N | not provided | Uncertain significance (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595029
- GRCh38:
- Chr2:157738517
| ACVR1 | S440G | not provided | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595037
- GRCh38:
- Chr2:157738525
| ACVR1 | N437S | not provided | Uncertain significance (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595039
- GRCh38:
- Chr2:157738527
| ACVR1 | | not provided | Likely benign (Nov 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595050
- GRCh38:
- Chr2:157738538
| ACVR1 | D433N | not provided | Uncertain significance (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595051
- GRCh38:
- Chr2:157738539
| ACVR1 | | not provided | Likely benign (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595057
- GRCh38:
- Chr2:157738545
| ACVR1 | | not provided | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158595089
- GRCh38:
- Chr2:157738577
| ACVR1 | | not provided | Likely benign (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617373
- GRCh38:
- Chr2:157760861
| ACVR1 | | not provided | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617403
- GRCh38:
- Chr2:157760891
| ACVR1 | M418T | not provided | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617414
- GRCh38:
- Chr2:157760902
| ACVR1 | | not provided | Uncertain significance (Jul 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617429
- GRCh38:
- Chr2:157760917
| ACVR1 | | not provided | Likely benign (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617452
- GRCh38:
- Chr2:157760940
| ACVR1 | V402I | not provided | Uncertain significance (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617458
- GRCh38:
- Chr2:157760946
| ACVR1 | K400E | not provided | Uncertain significance (Feb 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617478
- GRCh38:
- Chr2:157760966
| ACVR1 | V393G | not provided | Uncertain significance (Apr 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617504
- GRCh38:
- Chr2:157760992
| ACVR1 | | not provided | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617507
- GRCh38:
- Chr2:157760995
| ACVR1 | | not provided | Likely benign (Jan 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617514
- GRCh38:
- Chr2:157761002
| ACVR1 | Y381C | not provided | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617525
- GRCh38:
- Chr2:157761013
| ACVR1 | | not provided, Progressive myositis ossificans | Benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158617530
- GRCh38:
- Chr2:157761018
| ACVR1 | V376M | not provided | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617532
- GRCh38:
- Chr2:157761020
| ACVR1 | R375P | Progressive myositis ossificans | Pathogenic (Mar 1, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr2:158617547
- GRCh38:
- Chr2:157761035
| ACVR1 | V370A | not provided | Likely benign (Feb 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617570
- GRCh38:
- Chr2:157761058
| ACVR1 | | not provided, Progressive myositis ossificans | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158617576
- GRCh38:
- Chr2:157761064
| ACVR1 | M360I | not provided | Uncertain significance (Dec 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617583
- GRCh38:
- Chr2:157761071
| ACVR1 | A358E | Progressive myositis ossificans | Uncertain significance (Feb 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617589
- GRCh38:
- Chr2:157761077
| ACVR1 | G356D | not provided, Progressive myositis ossificans | Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158617602
- GRCh38:
- Chr2:157761090
| ACVR1 | | not provided | Likely benign (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158617814
- GRCh38:
- Chr2:157761302
| ACVR1 | | not provided | Benign (Jun 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622416
- GRCh38:
- Chr2:157765904
| ACVR1 | | not provided | Likely benign (Oct 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622461
- GRCh38:
- Chr2:157765949
| ACVR1 | K346N | not provided | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622470
- GRCh38:
- Chr2:157765958
| ACVR1 | | Progressive myositis ossificans | Uncertain significance (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622481
- GRCh38:
- Chr2:157765969
| ACVR1 | K340E | not provided | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622511
- GRCh38:
- Chr2:157765999
| ACVR1 | P330A | Inborn genetic diseases | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622511
- GRCh38:
- Chr2:157765999
| ACVR1 | P330S | not provided | Uncertain significance (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622516
- GRCh38:
- Chr2:157766004
| ACVR1 | G328V | Diffuse intrinsic pontine glioma | other | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622516
- GRCh38:
- Chr2:157766004
| ACVR1 | G328E | Inborn genetic diseases, Progressive myositis ossificans | Pathogenic/Likely pathogenic (Oct 12, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158622517
- GRCh38:
- Chr2:157766005
| ACVR1 | G328W | Progressive myositis ossificans | Pathogenic (Mar 1, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr2:158622517
- GRCh38:
- Chr2:157766005
| ACVR1 | G328R | Progressive myositis ossificans | Pathogenic (Mar 1, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr2:158622542
- GRCh38:
- Chr2:157766030
| ACVR1 | | not provided | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622579
- GRCh38:
- Chr2:157766067
| ACVR1 | R307Q | not provided, Inborn genetic diseases | Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:158622605
- GRCh38:
- Chr2:157766093
| ACVR1 | | not provided | Likely benign (Sep 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622620
- GRCh38:
- Chr2:157766108
| ACVR1 | | not provided | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622623
- GRCh38:
- Chr2:157766111
| ACVR1 | | not provided | Likely benign (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622629
- GRCh38:
- Chr2:157766117
| ACVR1 | | not provided | Benign (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622635
- GRCh38:
- Chr2:157766123
| ACVR1 | M288I | not provided | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158622679
- GRCh38:
- Chr2:157766167
| ACVR1 | H274Y | Progressive myositis ossificans | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:158626861
- GRCh38:
- Chr2:157770349
| ACVR1 | | not provided | Likely benign (Apr 8, 2022) | criteria provided, single submitter |